【摘 要】
：
The outcome of recurrent brain metastasis is dismal.This study aims to assess the clinical outcomes and toxicity of reirradiation as a salvage treatment for progressive brain metastasis in patients wi
【机 构】
：
Department of Radiotherapy, Affiliated Hospital of Academy of Military Medical Sciences, No.8 Dongda
论文部分内容阅读
The outcome of recurrent brain metastasis is dismal.This study aims to assess the clinical outcomes and toxicity of reirradiation as a salvage treatment for progressive brain metastasis in patients with advanced breast cancer.Between July 2005 and September 2014, the medical records of 56 patients with brain metastasis from breast cancer were retrospectively reviewed.Of these patients, 39 received whole-brain radiotherapy (WBRT) followed by stereotactic radiosurgery (SRS) reirradiation (Group 1), and 17 received SRS followed by WBRT reirradiation (Group 2).Overall survival (OS) and brain progression-free survival rates/times were calculated using the Kaplan-Meier method.Prognostic factors were evaluated using the Cox proportional hazards model.Change in neurologic function was also assessed.The median OS was 10.8 months (range, 1.3-56.8 months).In Group 1,the median PFS time (PFS-1) was 6.5 months and the OS time was 11.4 months.Multivariate analysis revealed that longer OS was significantly associated with a high Kamofsky performance score (KPS) (P =0.004), controlled extracranial metastasis (P =0.001) and a good response to reirradiation (P =0.034).In Group 2, the median PFS time (PFS-2) after reirradiation was 8.5 months and the OS time was 10.8 months.Multivariate analysis revealed that longer OS was significantly associated with a high KPS (P =0.018).The majority of the patients had improved or stable neurological function.Reirradiation is an effective and a safe treatment for patients with brain metastases from breast cancer.It might delay the progression of intracranial disease and improve neurological function.A suitable patient selection for reirradiation was suggested.
其他文献
目的：回顾性分析单中心头颈部黏膜恶性黑色素瘤的临床特征及治疗疗效.材料和方法：回顾性分析1981-2015年间医院收治的161例初诊无远地转移的头颈部黏膜恶性黑色素瘤的临床资料.其中男94例,女67例,发病年龄19-83岁(中位数54岁).最常见的原发部位为鼻腔(55％)和口腔(30％),其余部位包括副鼻窦(6％),眼睑(5％),鼻咽(2％)和口咽(2％).按第七版AJCC头颈部黏膜恶性黑色素瘤分
Purpose:The present clinical trial was designed to evaluate the efficacy and safety of concurrent helical tomotherapy (HT) with cetuximab followed by adjuvant chemotherapy with docetaxel and cisplatin
目的：早期乳腺癌保乳术后患者的预后与放疗获益,分析相关因素对预后的影响.方法：回顾分析医院1999年至2013年收治的1697例保乳术后早期乳腺癌患者,均未行新辅助化疗.中位年龄46岁(22-88).20例(1.1％)手术切缘阳性.术后病理分期pT1和pT2分别为1271例(74.9％)和426例(25.1％),pN0,pN1、pN2和pN3分别为1234例(72.7％)、334例(19.7％)、
目的：每日两次放疗(45Gy/30f,1.5Gy/f)或每日一次放疗(60-70Gy/30-35f,2.0Gy/f)联合EP方案化疗是NCCN指南局限期小细胞肺癌(LS-SCLC)的标准治疗方案.CONVERT研究比较了LS-SCLC每日两次放疗(45Gy/30f)与每日一次放疗(66Gy/33f)联合EP方案化疗的疗效,结果显示：每日两次放疗与每日一次放疗3年生存率无显著性差异(43％和39％)
目的：通过对射波刀呼吸追踪治疗肺部肿瘤的应用、体会,总结射波刀对肺部肿瘤治疗的优势,为进一步的应用、推广提供临床依据.方法：选择2013年12月至2015年10月收治的42例进行射波刀呼吸追踪治疗的肺部肿瘤患者,观察评估本组患者3个月和6个月的有效率和毒副反应发生情况.结果：42例患者均顺利完成治疗.3个月有效率为94％,6个月有效率为95％.发生急性放射性肺炎2例约占本组病例的5％、急性放射性食
目的：比较肺癌放疗过程中四维CT与传统方法勾画靶区的治疗计划差异性.方法：选取医院2013-01/2013-12间20例肺癌放疗患者为研究对象,对其进行四维CT与普通螺旋CT扫描,并且应用两种方法划定靶区与制定治疗计划,比较两种不同方法测定靶区的体积,分析其差异.结果：四维CT扫描勾画计划靶区体积为(277.4±33.6)cm3,普通螺旋CT扫描勾画计划靶区体积为(295.3±34.1)cm3.计
目的：探讨程序性死亡受体(PD)-1单克隆抗体治疗食管癌术后、化疗后转移性淋巴结的疗效.方法：回顾性分析1例使用PD-1单克隆抗体(pembrolizumab)治疗食管癌术后、化疗后淋巴结转移的临床资料.结果：患者食管癌术后、化疗后仍存在淋巴结转移,化疗后4个月内给予pembrolizumab治疗(100mg静脉滴,每2周一次),治疗后4周期后疗效评价为SD,8周期后疗效评价为PR.结论：食管癌术
目的：对SCLC患者外周血微环境中肿瘤相关细胞因子IL-2,IL-6,TGF-β1,HIF-1,PD-1,PD-L1,CTLA-4在治疗前,以及治疗的第1-7周期的动态表达进行检测,从细胞因子水平明确肿瘤患者全身免疫状况;为免疫治疗与化疗的结合寻找最佳切入点,并对治疗决策的制定提供依据.方法：收集43例ED/LD期SCLC患者外周血,利用ELISA方法检测该组患者外周血中IL-2,IL-6,TGF
Objective:To determine the high-risk population of breast cancer brain metastasis accompanied with severe peritumoral brain edema, and to probe into the effects of peritumoral brain edema degree on th
Previous studies have investigated the prognostic significance of B7 homolog 3 (B7-H3) in non-small cell lung cancer (NSCLC), however, the results remain controversial.This study was aimed to determin